Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
DNA, RNA & Cells
Filter     Order     Display # 
Date Item Title
02 Oct 2006 Antisoma announces positive phase I data on AS1411, plans phase II trials in renal and blood cancers
02 Oct 2006 Oxford Biomedica Expands Its Ocular Programme Through Collaboration And Investment Led By The Foundation Fighting Blindness
30 Sep 2006 FDA Issues Approvable Letter To Ortec International Inc. (ORTN.OB) For Use Of Cryopreserved OrCel(R) In Epidermolysis Bullosa Patients' Hand Reconstructions And Donor Sites
30 Sep 2006 AVI BioPharma Presents Positive Preclinical Data Evaluating NeuGene Antisense Compounds Against Influenza A Virus and the E. coli Bacteria
29 Sep 2006 Alnylam Awarded $23 Million U.S. Government Contract to Develop RNAi Therapeutics for Biological Threats
28 Sep 2006 Pervasis Therapeutics’ Vascugel(TM) Initiates U.S. Clinical Trials Following Successful FDA IND Review
28 Sep 2006 Sangamo BioSciences Announces Positive HIV/CCR5-ZFN Data in Presentation at 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
26 Sep 2006 Alnylam Grants Quark a License to Develop and Commercialize Two RNAi Therapeutic Products
26 Sep 2006 Pfizer Expands Research Commitment to Ophthalmology Through Licensing Agreement With Quark Biotech
21 Sep 2006 MOLOGEN AG: Exclusivity for Cell-based Cancer Treatment
21 Sep 2006 Biogen Idec and Alnylam Form Alliance to Discover and Develop Therapeutics for the Potential Treatment of Progressive Multifocal Leukoencephalopathy (PML); Collaboration to Focus on RNAi Therapeutics Targeting the JC Virus
19 Sep 2006 Topigen Pharmaceuticals Inc. Begins IND-Enabling Studies For TPI-1100 the First RNA-Targeting Compound To Treat COPD
16 Sep 2006 Final Report Of Genasense Phase 3 Trial In Melanoma Published In Journal Of Clinical Oncology
16 Sep 2006 MediGene: Dose-Finding Trial of Oncolytic Virus NV1020 for the Treatment of Liver Metastases Shows Efficacy Trends
16 Sep 2006 Aastrom Biosciences Reports Interim Data From Long Bone Non-Union Fracture Clinical Trial
14 Sep 2006 Cobra to support novel gene therapy trials
14 Sep 2006 SR Pharma plc Announces Encouraging Results for Atu027 RNAi Showing Therapeutic Efficacy in Mouse Models of Pancreatic Cancer
13 Sep 2006 Ortec Announces Positive Results in Confirmatory Venous Leg Ulcer Trial
12 Sep 2006 Acuity Pharmaceuticals Reports Positive Phase II Results for Bevasiranib in Wet AMD
09 Sep 2006 BioLineRx In-Licenses Novel Antisense Drug for the Treatment of Inflammatory Diseases
07 Sep 2006 Introgen's ADVEXIN Therapy Shows Promise in the Treatment of Breast Cancer
07 Sep 2006 FDA Advisory Committee Reviews Genasense(R) for Treatment of Chronic Lymphocytic Leukemia
25 Aug 2006 Dendreon Submits Clinical and Non-Clinical Sections of Rolling BLA to FDA for PROVENGE to Treat Advanced Prostate Cancer Patients
24 Aug 2006 Further Positive Phase II Results of Trinam Gene Therapy
23 Aug 2006 Oncolytics Biotech Inc. Completes Patient Enrolment in U.S. Phase I Systemic Administration Clinical Trial
18 Aug 2006 Argos Therapeutics Initiates Phase I/II Trial with AGS-003 Personalized Immunotherapy in Advanced Kidney Cancer; Trial to Evaluate New Production Process That May Yield More Potent Immune Response
16 Aug 2006 co.don AG - Excellent results of GCP-study EuroDISC on ADCT treatment of disc herniation and low back pain
16 Aug 2006 Enzo Biochem Reports Long Term Retention Of Antisense RNA In Phase I Study Of HIV-1 Infected Subjects
10 Aug 2006 Sirna Therapeutics Reports Final Results From Phase 1 Study On Its RNAi-Based Therapeutic For Age-Related Macular Degeneration
10 Aug 2006 Introgen Therapeutics Announces Key Regulatory Advance for ADVEXIN Program
09 Aug 2006 Bioheart Acquires Exclusive Option Rights to Tissue Genesis' Cell Technology for the Acute Treatment of Heart Attacks
07 Aug 2006 MicroIslet Transplantation Studies in Diabetic Primates Successful at Six-Month Milestone
07 Aug 2006 Diamyd Medical Outlicenses Gene To Neurologix For Treatment Of Parkinson’s Disease
01 Aug 2006 co.don® AG –successful arthroscopic treatment of ankle
01 Aug 2006 Archemix and Nuvelo Expand Collaboration and Nominate New Clinical Compound
27 Jul 2006 Enzon Pharmaceuticals and Santaris Pharma Enter into Global Collaboration to Develop Novel Cancer Therapeutics; Alliance Strengthens Both Companies' Oncology Pipelines
27 Jul 2006 Aida Pharmaceuticals Announces Completion of Phase I Trials for Gene-Therapy Drug
26 Jul 2006 Genta Receives Special Protocol Assessment from FDA for Confirmatory Trial of Genasense(R) Plus Chemotherapy in Chronic Lymphocytic Leukemia
25 Jul 2006 co.don AG - world wide revolutionary Enhancement of Product Portfolio and Indication
25 Jul 2006 TissueGene Initiates Phase I Clinical Trial with TG-C
25 Jul 2006 ViaCell Announces Completion of CB001 Phase I Clinical Trial
21 Jul 2006 AVI BioPharma Announces Hepatitis C Virus Clinical Study Modification
19 Jul 2006 Geron Announces Publication of Study Results Supporting Safety and Utility of Human Embryonic Stem Cell-Derived Therapeutic Product for Treatment of Spinal Cord Injury
19 Jul 2006 Cell Genesys Launches Expanded Multiple-Dose Phase 1 Trial of CG0070 in Recurrent Bladder Cancer
19 Jul 2006 TOPIGEN Reports Positive Therapeutic Results from Initial Phase II Trial Studying Inhaled TPI-ASM8 in Patients with Mild-to-Moderate Asthma
18 Jul 2006 Oncolytics Biotech Inc. Announces Approval for Phase II U.K. Clinical Trial Investigating REOLYSIN® in Combination with Radiation Therapy
18 Jul 2006 TOPIGEN Reports Positive Therapeutic Results from Initial Phase II Trial Studying Inhaled TPI-ASM8 in Patients with Mild-to-Moderate Asthma
18 Jul 2006 Alnylam Announces Collaboration with University of Texas Southwestern Medical Center to Discover RNAi Therapeutics for Hypercholesterolemia; Collaboration to Focus on PCSK9, a Key Gene Involved in Metabolism of LDL-Cholesterol
13 Jul 2006 Corautus Genetics Announces Partial Lifting of FDA Clinical Hold and Update on GENASIS Database Lock
11 Jul 2006 Oncolytics Biotech Inc. Begins Patient Enrolment in U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 401 - 450 of 599

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics